NEW YORK (GenomeWeb News) – Roche today reported that sales in its diagnostics division grew 5 percent year over year at constant exchange rates during the first half of 2012 while the molecular diagnostics business grew 6 percent.

For the six months ending June 30, the Swiss drug and diagnostics firm reported diagnostic sales of CHF 5.01 billion ($5.13 billion) compared to CHF 4.86 billion during the first half of 2011. In Swiss francs the division grew 3 percent, and in dollars first-half 2012 sales were up 1 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.